A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours - Concepedia

Concepedia

Publication | Open Access

A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours

DOI Full Paper Access

177

Citations

31

References

2013

Year

Michael Warso, Jon Richards, Divya Mehta, Konstantin Christov, Cynthia Schaeffer, Linda R. Bressler, Tohru Yamada, D. Majumdar, Sean Kennedy, Craig W. Beattie,

British Journal of Cancer

References

	Year	Citations

Page 1